Index falls as earnings results weigh; pound above $1.33, Bodycote soars
ATLANTA, GA - Nocera , Inc. (NASDAQ:NCRA), a company specializing in livestock and animal specialties with a market capitalization of $14.2 million and currently trading at $1.01 per share, announced today that it will restate financial statements for three quarters of 2024 due to material errors. According to InvestingPro analysis, the company’s stock has shown significant volatility, with a 19.3% gain year-to-date despite recent challenges. The Board of Directors, after consulting with the company’s independent accounting firm, determined that the financial reports for the quarters ending March 31, June 30, and September 30 of 2024 cannot be relied upon.
The inaccuracies are related to the misaccounting of changes in the fair value of the company’s warrant liability. Specifically, a decrease in the fair value of its warrant liability amounting to $552,173 was not recognized in the company’s operations for the periods in question. This oversight led to the warrant liability being overstated by approximately 70%, and total liabilities by 35%, on the balance sheet as of September 30, 2024. The error also significantly affected the reported net loss of $1.16 million for the year 2024.
As a result, the unaudited financial statements for the affected quarters will be restated to reflect the correct fair value of the warrant liability in compliance with Generally Accepted Accounting Principles (GAAP). The forthcoming Annual Report on Form 10-K for the fiscal year ended December 31, 2024, which is expected to be filed by April 15, 2025, will include restated financial statements for the affected quarters as footnotes, along with a note detailing the restatements’ background and impact.
The company also identified a material weakness in its internal controls over financial reporting related to the evaluation and measurement of warrant liabilities. Consequently, the effectiveness of the company’s disclosure controls and procedures for the quarters ended March 31, June 30, and September 30 of 2024 has been called into question.
The issues disclosed are based on a statement from the company’s SEC filing. Nocera has communicated the restatement and related issues with its independent registered public accounting firm, Enrome LLP. The company is working to address the identified material weakness to prevent recurrence.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.